Firefly Neuroscience (NASDAQ:AIFF – Get Free Report) and SUIC Worldwide (OTCMKTS:SUIC – Get Free Report) are both small-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations.
Institutional & Insider Ownership
5.0% of Firefly Neuroscience shares are owned by institutional investors. 6.4% of Firefly Neuroscience shares are owned by company insiders. Comparatively, 65.8% of SUIC Worldwide shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Profitability
This table compares Firefly Neuroscience and SUIC Worldwide’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Firefly Neuroscience | -2,705.88% | -319.00% | -191.27% |
| SUIC Worldwide | N/A | N/A | -634.96% |
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Firefly Neuroscience | $110,000.00 | 239.15 | -$10.46 million | ($2.09) | -0.89 |
| SUIC Worldwide | $150,000.00 | 29.23 | -$230,000.00 | N/A | N/A |
SUIC Worldwide has higher revenue and earnings than Firefly Neuroscience.
Volatility and Risk
Firefly Neuroscience has a beta of 1.92, meaning that its share price is 92% more volatile than the S&P 500. Comparatively, SUIC Worldwide has a beta of 38.38, meaning that its share price is 3,738% more volatile than the S&P 500.
Analyst Recommendations
This is a summary of recent recommendations for Firefly Neuroscience and SUIC Worldwide, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Firefly Neuroscience | 1 | 0 | 0 | 0 | 1.00 |
| SUIC Worldwide | 0 | 0 | 0 | 0 | 0.00 |
Summary
SUIC Worldwide beats Firefly Neuroscience on 6 of the 10 factors compared between the two stocks.
About Firefly Neuroscience
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
About SUIC Worldwide
Suic Worldwide Holdings Ltd is venture capital firm specializing in growth capital investments. The firm seeks to invest in private enterprises and the public sector that develop products and services adopting core capabilities of the IoT, big data, AI, fintech and blockchain. The firm provides IT management consulting services. Suic Worldwide Holdings Ltd was formerly known as Sino United Worldwide Consolidated Ltd. Suic Worldwide Holdings Ltd was incorporated in 2006 and is headquartered in Flushing, New York.
Receive News & Ratings for Firefly Neuroscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Firefly Neuroscience and related companies with MarketBeat.com's FREE daily email newsletter.
